Professor Natan Tzvi Shaked,Qart Co-Founder and CSO, Invited to Speak at Aspire’s 2024 Conference in Manilla
QART CO-FOUNDER AND CHIEF SCIENTIFIC OFFICER, PROFESSOR NATAN TZVI SHAKED – AN INVITED SPEAKER AT ASPIRE’S 2024 CONFERENCE IN MANILLA, PHILIPPINES
Raanana, Israel; June 2024
QART Medical’s co-founder and chief scientific officer, was invited to speak at the 13th congress of the Asia Pacific Initiative on Reproduction’s (ASPIRE) in Manilla, Philippines. Prof Shaked, in his Academic role, is director of biomedical engineering at Tel-Aviv University.
Professor Shaked’s ASPIRE talk, titled “Sperm DNA Fragmentation Assay for Live Human Sperm During ICSI”, detailed the years of research output from the Biomedical OMNI (Optical Microscopy, Nanoscopy, and Interferometry) Group that he leads at Tel Aviv University that led to the spin out of QART Medical. Additionally, he explained the advanced research and development that he leads, to bring real time DNA fragmentation analysis, on a single-cell level, to its flagship product, the Q300™.
Following the talk and a Q&A session, Prof Shaked participated in a panel discussion, revolving around the importance of assessing DNA fragmentation in live, motile human sperm cells, to optimize IVF success rates.
ASPIRE, the Asia Pacific Initiative on Reproduction, was founded in 2001 by Bruno Lunenfeld and P C Wong, to improve knowledge and awareness of ART and infertility-related services, with the ultimate aim of improving the quality of patient care.